Related Experiment Video
Updated: Sep 11, 2025

A Two-Step Method for Percutaneous Transhepatic Choledochoscopic Lithotomy
Published on: September 13, 2022
A comparative study of extracorporeal shock wave lithotripsy and cholangioscopy-guided lithotripsy in the management
Hayat Khizar1, Weigang Gu, Haibin Zhou
1From the Department of Gastroenterology (H.K., W.G., H.Z., J.Y., H.J., X.H., X.Z., J.Y.), Hangzhou First People's Hospital, Hangzhou, Zhejiang; Department of Surgery (H.K.), The Fourth Affiliated Hospital, International Institute of Medicine, Zhejiang University School of Medicine, Hangzhou; Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province (J.Y.); Key Laboratory of Integrated Traditional Chinese and Western Medicine for Biliary and Pancreatic Diseases of Zhejiang Province (J.Y.); and Hangzhou Institute of Digestive Diseases (J.Y.), Hangzhou, Zhejiang, China.
Background:
Large and impacted common bile duct stones (CBDSs) cannot be removed by conventional endoscopic retrograde cholangiopancreatography (ERCP), and extracorporeal shock wave lithotripsy (ESWL) or cholangioscopy-guided lithotripsy is recommended as a second-line treatment. The aim of this study is to compare safety and efficacy of ESWL for difficult CBDS.
Methods:
Patients at our hospital diagnosed with complex large CBDS between January 2021 and June 2022 were randomly assigned to the ESWL group or the cholangioscopy group for lithotripsy. Our results include clinical and technical success, the mean number of ERCP sessions, and any complications from the procedure.
Results:
A total of 84 patients were included assigned to two groups (the ESWL group [42 patients] and the cholangioscopy group [42 patients]). Technical success was 92.85% for the ESWL group and 100% for the cholangioscopy group ( p = 0.19), whereas clinical success was 69% and 88%, respectively ( p = 0.01). The ESWL group had 2.32 ± 0.98 ERCPs, and the cholangioscopy group had 1.13 ± 0.36 ( p < 0.001). The mean lithotripsy sessions were 2.3 ± 0.63 for ESWL and 1.13 ± 0.36 for cholangioscopy ( p < 0.001). Both groups had similar adverse events, except for cutaneous petechiae.
Conclusion:
Compared with ESWL, cholangioscopy-guided lithotripsy is a safe and effective treatment for large and complex CBDSs.
Level Of Evidence:
Therapeutic/Care Management; Level II.
More Related Videos
Related Concept Videos
Urinary Tract Calculi VI: Surgical Management
Urinary Tract Calculi III: Medical Management
Endoscopic Procedures V: ERCP
Patient...
Imaging Studies V: Intravenous Urography and Retrograde Pyelography
Chronic Pancreatitis II: Collaborative Care
Assessment:
Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):

